摘要
目的:建立UPLC法同时测定冠脉康片中3种成分(三七皂苷R_1、人参皂苷Rg_1及人参皂苷Rb1)的含量。方法:采用Waters ACQUITY UPLCBEH C_(18)柱(5mm×210mm,1.7μm),以乙腈-水溶液为流动相,梯度洗脱,流速为0.6mL·min-1,检测波长为203nm,柱温为25℃。结果:人参皂苷Rg1、人参皂苷Rb_1及三七皂苷R_1的线性范围分别为0.003 8~0.041 8μg(r=0.999 7)、0.062 4~0.686 4μg(r=0.999 7)、0.005 8~0.063 8μg(r=0.999 9);平均加样回收率分别为101.24%、98.12%、100.33%;RSD(n=6)分别为1.34%、1.82%、1.55%。结论:该方法稳定、快速、专属性强,可用于冠脉康片中人参皂苷Rg1、人参皂苷Rb1及三七皂苷R_1的含量测定及其质量控制。
Objective:To establish a RP-UPLC method for simultaneous determination of Ginsenoside Rg1,Rb1 and Notoginsenoside R1 in Guanmaikang Tablet.Methods:The separation was performed on a Waters ACQUITY UPLCR BEH C18column(5mm×210mm,1.7μm)with gradient elution(0~4min,A:18%;4~5.5min,A:18%~20%;5.5~6.5min,A:20%;6.5~7min,A:20%~28%;7~12.5min,A:28%~30%;12.5~13min,A:30%~90%;13~16min,A:90 %)using acetonitrile(A)and water(B)as mobile phase at a flow rate of 0.6mL·min-1.The detection wavelengths was 203 nm.Results:Linear ranges of Ginsenoside Rg1,Rb1 and Notoginsenoside R1 were 0.003 8~0.041 8μg(r=0.999 7),0.062 4~0.686 4μg(r=0.999 7),0.005 8~0.063 8μg(r=0.999 9),respectively.The average recoveries(n=6)of the three lignans were 101.24%,98.12%,100.33%;RSDs were 1.34%,1.82%,1.55%,respectively.Conclusion:The method is sensitive,accurate and can be used to determine the contents of Ginsenoside Rg1,Rb1 and Notoginsenoside R1 in Guanmaikang Tablet,which may also be applied as a standard for the quality control of in Guanmaikang Tablet.
出处
《亚太传统医药》
2016年第6期29-31,共3页
Asia-Pacific Traditional Medicine